Bristol Baraclude Will Be Available April 8; Premium Price Planned
Bristol-Myers Squibb's Baraclude (entecavir) will be available on pharmacy shelves April 8 following FDA approval of the hepatitis B therapy
Bristol-Myers Squibb's Baraclude (entecavir) will be available on pharmacy shelves April 8 following FDA approval of the hepatitis B therapy